Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2020 Financial Results and Provide Corporate Update

Rhea-AI Summary

Xenon Pharmaceuticals Inc. (Nasdaq:XENE) announced it will publish its Q2 2020 financial and operational results on August 6, 2020, post-market close. The company will host a conference call at 4:30 PM ET to discuss the results and provide a corporate update. Interested participants can join by dialing (855) 779-9075, with a replay available for 30 days following the call. Xenon focuses on developing innovative therapeutics for neurological disorders, particularly in epilepsy.

Positive

• Scheduled Q2 2020 results release on August 6, 2020.
• Focus on developing neurologic therapeutics addressing high unmet medical needs.

Negative

• None.

BURNABY, British Columbia, July 30, 2020 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced that it will report its second quarter 2020 financial and operating results after the close of U.S. financial markets on Thursday, August 6, 2020. Xenon management will host a conference call and live audio webcast at 4:30 pm Eastern Time (1:30 pm Pacific Time) to discuss the results and to provide a corporate update.

To participate in the call, please dial (855) 779-9075, or (631) 485-4866 for international callers, and provide conference ID number 4056993. The webcast will be broadcast live on the “Investors” section of Xenon's website at www.xenon-pharma.com and will be available for replay following the call for 30 days.

About Xenon Pharmaceuticals Inc.

We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the
lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to

address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: investors@xenon-pharma.com

FAQ

When will Xenon Pharmaceuticals report Q2 2020 financial results?

Xenon Pharmaceuticals will report its Q2 2020 financial results on August 6, 2020, after the close of U.S. financial markets.

What time is the Xenon Pharmaceuticals conference call for Q2 2020 results?

The conference call for Xenon Pharmaceuticals' Q2 2020 results is scheduled for 4:30 PM ET on August 6, 2020.

How can I access the Xenon Pharmaceuticals Q2 2020 results webcast?

The Q2 2020 results webcast can be accessed live on the 'Investors' section of Xenon Pharmaceuticals' website.

What is the focus of Xenon Pharmaceuticals' product pipeline?

Xenon Pharmaceuticals is focused on developing therapeutics for neurological disorders, particularly epilepsy.